Herbas VPB

Print
EN | LT
LT - 2,4-Pirimidindiaminų panaudojimas aterosklerozės gydymui
EN - USE OF 2,4-PYRIMIDINEDIAMINES FOR THE TREATMENT OF ATHEROSCLEROSIS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/5383 (2006.01)
A61K 31/662 (2006.01)
A61P 9/10 (2006.01)
European patent
(11) Number of the document 2252300
(13) Kind of document T
(96) European patent application number 09711944.0
Date of filing the European patent application 2009-02-20
(97) Date of publication of the European application 2010-11-24
(45) Date of publication and mention of the grant of the patent 2016-10-19
(46) Date of publication of the claims translation 2017-02-10
PCT application
(86) Number PCT/US2009/034718
Date 2009-02-20
PCT application publication
(87) Number WO 2009/105675
Date 2009-08-27
Priority applications
(30) Number Date Country code
30903 2008-02-22 US
Inventors
(72)
MASUDA, Esteban, US
SCHMITZ, Jochen, US
Grantee
(73) Rigel Pharmaceuticals, Inc., 1180 Veterans Boulevard, South San Francisco, CA 94080, US
Attorney or representative
(74) Liudmila GERASIMOVIČ, IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius, LT
Title
(54) 2,4-Pirimidindiaminų panaudojimas aterosklerozės gydymui
  USE OF 2,4-PYRIMIDINEDIAMINES FOR THE TREATMENT OF ATHEROSCLEROSIS
Last renewal fee
Payment date Validity (years) Amount
2023-01-31 15 289.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2024-02-20